Postnatale Infektionen bei Frühgeborenen

Alexander Humberg

doi:10.1055/a-2118-1320

Neonatologie Scan, Table of Contents

Neonatologie Scan 2024; 13(04): 295-310
DOI: 10.1055/a-2118-1320

CME-Fortbildung

Postnatale Infektionen bei Frühgeborenen

Neurologische und respiratorische Langzeitkomplikationen

Alexander Humberg

Abstract

Frühgeborene haben ein erhöhtes Risiko für eine Vielzahl von Komplikationen. Mit Erreichen einer sehr guten Überlebensfähigkeit von Frühgeborenen in Ländern mit gut ausgestatteten Gesundheitssystemen stellt sich die Frage der Lebensqualität der Kinder und der Identifikation von Faktoren, um diese Qualität zu verbessern. Die Kontrolle von Infektionen spielt hier eine wichtige Rolle, da diese einen Einfluss auf die Langzeitgesundheit von Frühgeborenen haben.

Schlüsselwörter

neonatale Infektion - Zerebralparese - chronische Lungenerkrankung - Frühgeborenes - bronchopulmonale Dysplasie

Full Text

References

Literatur
1 Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371: 261-269
2 Pierrat V, Marchand-Martin L, Arnaud C. et al. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort study. BMJ 2017; 358: j3448
3 Platt MJ. Outcomes in preterm infants. Public Health 2014; 128: 399-403
4 Humberg A, Fortmann I, Siller B. et al. Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol 2020; 42: 451-468
5 Coggins SA, Glaser K. Updates in late-onset sepsis: risk assessment, therapy, and outcomes. Neoreviews 2022; 23: 738-755
6 Villamor-Martinez E, Lubach GA, Rahim OM. et al. Association of histological and clinical chorioamnionitis with neonatal sepsis among preterm infants: a systematic review, meta-analysis, and meta-regression. Front Immunol 2020; 11: 972
7 Stoll BJ, Hansen N, Fanaroff AA. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002; 110: 285-291
8 Shah J, Jefferies A, Yoon E. et al. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at <32 weeks’ gestation. Am J Perinatol 2014; 32: 675-682
9 Hornik CP, Fort P, Clark RH. et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88: S69-S74
10 Kuppala VS, Meinzen-Derr J, Morrow AL. et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011; 159: 720-725
11 Spiegler J, Preuß M, Gebauer C. et al. Does breastmilk influence the development of bronchopulmonary dysplasia?. J Pediatr 2016; 169: 76-80.e4
12 Köstlin-Gille N, Härtel C, Haug C. et al. Epidemiology of early and late onset neonatal sepsis in very low birthweight infants. Pediatr Infect Dis J 2021; 40: 255-259
13 Dong Y, Speer CP, Glaser K. Beyond sepsis: staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity. Virulence 2018; 9: 621-633
14 Humberg A, Fortmann MI, Spiegler J. et al. Recurrent late-onset sepsis in extremely low birth weight infants is associated with motor deficits in early school age. Neonatology 2022; 119: 695-702
15 Strunk T, Prosser A, Levy O. et al. Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatr Res 2012; 72: 10-18
16 Tsai M-H, Hsu J-F, Chu S-M. et al. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 2014; 33: e7-e13
17 Boghossian NS, Page GP, Bell EF. et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr 2013; 162: 1120-1124.e1
18 Boghossian NS, Page GP, Bell EF. et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr 2013; 162: 1120-1124.e1
19 Greenberg RG, Kandefer S, Do BT. et al. Late-onset sepsis in extremely premature infants. Pediatr Infect Dis J 2017; 36: 774-779
20 Vergnano S, Menson E, Kennea N. et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96: F9-F14
21 Civardi E, Tzialla C, Baldanti F. et al. Viral outbreaks in neonatal intensive care units: what we do not know. Am J Infect Control 2013; 41: 854-856
22 Caserta MT, Yang H, Gill SR. et al. Viral respiratory infections in preterm infants during and after hospitalization. J Pediatr 2017; 182: 53-58.e3
23 Stoll BJ, Hansen N, Fanaroff AA. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002; 110: 285-291
24 Dong Y, Glaser K, Speer CP. Late-onset sepsis caused by Gram-negative bacteria in very low birth weight infants: a systematic review. Expert Rev Anti Infect Ther 2019; 17: 177-188
25 Humberg A, Härtel C, Rausch TK. et al. Active perinatal care of preterm infants in the German Neonatal Network. Arch Dis Child Fetal Neonatal Ed 2020; 105: 190-195
26 Greenberg RG, Kandefer S, Do BT. et al. Late-onset sepsis in extremely premature infants. Pediatr Infect Dis J 2017; 36: 774-779
27 Regev RH, Arnon S, Litmanovitz I. et al. Association between neonatal morbidities and head growth from birth until discharge in very-low-birthweight infants born preterm: a population-based study. Dev Med Child Neurol 2016; 58: 1159-1166
28 Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008; 93: F153-61
29 Lawson LJ, Perry VH. The unique characteristics of inflammatory responses in mouse brain are acquired during postnatal development. Eur J Neurosci 1995; 7: 1584-1595
30 Mazaheri F, Breus O, Durdu S. et al. Distinct roles for BAI1 and TIM-4 in the engulfment of dying neurons by microglia. Nat Commun 2014; 5: 4046
31 Paolicelli RC, Bolasco G, Pagani F. et al. Synaptic pruning by microglia is necessary for normal brain development. Science (1979) 2011; 333: 1456-1458
32 Bokobza C, Van Steenwinckel J, Mani S. et al. Neuroinflammation in preterm babies and autism spectrum disorders. Pediatr Res 2019; 85: 155-165
33 Norden DM, Fenn AM, Dugan A. et al. TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 2014; 62: 881-895
34 Shiow LR, Favrais G, Schirmer L. et al. Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury. Glia 2017; 65: 2024-2037
35 Leviton A, Gilles F, Neff R. et al. Multivariate analysis of risk of perinatal telencephalic leucencephalopathy. Am J Epidemiol 1976; 104: 621-626
36 Bangma JT, Hartwell H, Santos HP. et al. Placental programming, perinatal inflammation, and neurodevelopment impairment among those born extremely preterm. Pediatr Res 2021; 89: 326-335
37 Glass TJA, Chau V, Grunau RE. et al. Multiple postnatal infections in newborns born preterm predict delayed maturation of motor pathways at term-equivalent age with poorer motor outcomes at 3 years. J Pediatr 2018; 196: 91-97.e1
38 Wang X, Stridh L, Li W. et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a myd88-dependent manner. J Immunol 2009; 183: 7471-7477
39 Cai S, Thompson DK, Anderson PJ. et al. Short- and long-term neurodevelopmental outcomes of very preterm infants with neonatal sepsis: a systematic review and meta-analysis. Children 2019; 6: 131
40 Humberg A, Spiegler J, Fortmann MI. et al. Surgical necrotizing enterocolitis but not spontaneous intestinal perforation is associated with adverse neurological outcome at school age. Sci Rep 2020; 10: 2373
41 Lee ES, Kim E-K, Shin S han. et al. Factors associated with neurodevelopment in preterm infants with systematic inflammation. BMC Pediatr 2021; 21: 114
42 Dubner SE, Dodson CK, Marchman VA. et al. White matter microstructure and cognitive outcomes in relation to neonatal inflammation in 6-year-old children born preterm. Neuroimage Clin 2019; 23: 101832
43 Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol 2013; 33: 558-564
44 Stoll B, Hansen N, Adams-Chapman I. et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-65
45 Kuban KCK, Joseph RM, O’Shea TM. et al. Circulating inflammatory-associated proteins in the first month of life and cognitive impairment at age 10 years in children born extremely preterm. J Pediatr 2017; 180: 116-123.e1
46 Mukhopadhyay S, Puopolo KM, Hansen NI. et al. Neurodevelopmental outcomes following neonatal late-onset sepsis and blood culture-negative conditions. Arch Dis Child Fetal Neonatal Ed 2021; 106: 467-473
47 Mitha A, Foix-L’Hélias L, Arnaud C. et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics 2013; 132: e372-80
48 Bright HR, Babata K, Allred EN. et al. Neurocognitive outcomes at 10 years of age in extremely preterm newborns with late-onset bacteremia. J Pediatr 2017; 187: 43-49.e1
49 van Tilborg E, Achterberg EJM, van Kammen CM. et al. Combined fetal inflammation and postnatal hypoxia causes myelin deficits and autism-like behavior in a rat model of diffuse white matter injury. Glia 2018; 66: 78-93
50 Twisselmann N, Pagel J, Künstner A. et al. Hyperoxia/hypoxia exposure primes a sustained pro-inflammatory profile of preterm infant macrophages upon LPS stimulation. Front Immunol 2021; 12: 762789
51 Novak I, Morgan C, Adde L. et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr 2017; 171: 897-907
52 Shahzad T, Radajewski S, Chao C-M. et al. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr 2016; 3: 23
53 Guo R-F, Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 2007; 9: 1991-2002
54 Galani V, Tatsaki E, Bai M. et al. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 2010; 206: 145-150
55 Simmons J, Pittet J-F. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 2015; 28: 227-236
56 Principi N, Di Pietro GM, Esposito S. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies. J Transl Med 2018; 16: 36
57 Davidson L, Berkelhamer S. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med 2017; 6: 4
58 Leroy S, Caumette E, Waddington C. et al. A time-based analysis of inflammation in infants at risk of bronchopulmonary dysplasia. J Pediatr 2018; 192: 60-65.e1
59 Härtel C, Pagel J, Spiegler J. et al. Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics. Sci Rep 2017; 7: 5633
60 Heydarian M, Schulz C, Stoeger T. et al. Association of immune cell recruitment and BPD development. Mol Cell Pediatr 2022; 9: 16
61 Bonadies L, Zaramella P, Porzionato A. et al. Present and future of bronchopulmonary dysplasia. J Clin Med 2020; 9: 1539
62 Tuková J, Koucký V, Marková D. et al. Symptomatic preterm infants suffer from lung function deficits, regardless of bronchopulmonary dysplasia. Pediatr Pulmonol 2022; 57: 3119-3128
63 Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 1967; 276: 357-368
64 O’Brodovich HM, Mellins RB. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis 1985; 132: 694-709
65 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729
66 Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 179-184
67 Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717
68 Nuthakki S, Ahmad K, Johnson G. et al. Bronchopulmonary dysplasia: ongoing challenges from definitions to clinical care. J Clin Med 2023; 12: 3864
69 Bonadies L, Cavicchiolo ME, Priante E. et al. Prematurity and BPD: what general pediatricians should know. Eur J Pediatr 2023; 182: 1505-1516
70 Yang Y, Li J, Mao J. Early diagnostic value of C-reactive protein as an inflammatory marker for moderate-to-severe bronchopulmonary dysplasia in premature infants with birth weight less than 1500 g. Int Immunopharmacol 2022; 103: 108462
71 Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med 2017; 132: 170-177
72 Schelonka RL, Katz B, Waites KB. et al. Critical appraisal of the role of ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 2005; 24: 1033-1039
73 Lowe J, Watkins WJ, Edwards MO. et al. Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants. Pediatr Infect Dis J 2014; 33: 697-702
74 Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100: 145-157
75 Klinger G, Levy I, Sirota L. et al. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 2010; 125: e736-e740
76 Marshall DD, Kotelchuck M, Young TE. et al. Risk factors for chronic lung disease in the surfactant era: a north carolina population-based study of very low birth weight infants. Pediatrics 1999; 104: 1345-1350
77 Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009; 123: 1314-1319
78 Humberg A, Fortmann I, Siller B. et al. Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol 2020; 42: 451-468
79 Groneck P, Reuss D, Götze-Speer B. et al. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993; 122: 938-944
80 Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-336
81 van de Loo M, van Kaam A, Offringa M. et al. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. Cochrane Database Syst Rev 2024; 4: CD013271